Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (OTCQB:ACUR)

0.50
Real-Time Quote
As of 10:34am ET
 +0.0089 / +1.81%
Today’s Change
0.40
Today|||52-Week Range
3.28
-34.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$5.8M

Company Description

Acura Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development, and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Contact Information

Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine Illinois 60067
P:(847) 705-7709
Investor Relations:

Employees

Shareholders

Individual stakeholders18.63%
Other institutional0.87%
Mutual fund holders0.21%

Top Executives

Robert B. JonesPresident, Chief Executive Officer & Director
Peter A. ClemensCFO, Secretary, SVP & Head-Investor Relations
Albert W. BrzeczkoVice President-Technical Affairs
Bob SeiserTreasurer, Vice President & Controller
James F. EmighVice President-Corporate Development